Challenges To The Management Of Psychiatric Hospitals Caused By The Continued Positive Antibodies Of Patients With Schizophrenia After Covid-19: Two Case Reports
- Author:
Jun Ma
1
,
2
;
Lin Zhang
1
,
2
;
Gang Wang
1
,
2
;
Yi Li
1
,
2
;
Xuebing Liu
1
,
2
Author Information
- Publication Type:Review
- Keywords: SARS-CoV-2 Antibody, IgM, IgG, COVID-19, Schizophrenia
- From:ASEAN Journal of Psychiatry 2021;22(6):1-6
- CountryMalaysia
- Language:English
- Abstract: In the context of the global pandemic of COVID-19, with the epidemic epicenter located in the Wuhan City, China, patients with severe mental illness have also been deeply affected by the epidemic. In this paper, two patients with schizophrenia who recovered from COVID-19 were reported. Because of the long-term positive results of the SARS-CoV-2 serum antibody IgM test, they had to undergo medical isolation and social restrictions for a long time. After the situation was effectively identified by the medical staff and they were eliminated as a potential virus carrier and released from the medical isolation center. Since psychiatrists often lack systematic knowledge of infectious diseases, the authors hope that this paper can provide a reference to avoid unnecessary wastage of medical resources and prevent placing serious mental burden on such patients in the future.
- Full text:17.2021my0028.pdf
